Pharmas sued for alleged scheme to fix prices of antidepressant
A healthcare benefits fund based in New York filed a putative class action against several pharmaceutical companies on Friday for allegedly conspiring to raise the prices of generic amitriptyline, a tricyclic antidepressant tablet.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10